Nexant calls for more EU support for biotechnology development

In England, Nexant, as a co-sponsor of the recent Fifth World Bio-Based Chemicals Conference in Rotterdam, led discussions with key bio-based chemical industry participants on topics ranging from pending product launches to achieving commercial-scale production and financing in the current global marketplace.

“One of the key aspects emerging from our industry dialogue was that North America is now outpacing Europe in the field of bio-derived chemicals, thanks in part to a more supportive regulatory environment,” said Nexant Vice President Jonathan Bourne, who chaired the discussions. “The EU needs to be more decisive in supporting new and emerging technologies to increase self-sufficiency in energy and materials, which in turn could lead to a more favorable trade balance with other regions.” In agreement, Nexant VP Richard Sleep stated, “… it is the uncertainty of the regulatory environment and its impact on demand and pricing—and therefore its impact on overall project economics—that is dominating thinking throughout the industry.”

More on the story.